ERBB2 and neoplasm: It has been proposed that tumors with greater neoantigen synthesis–such as TN and Her2-positive- may achieve a higher immune anti-tumor response by increasing numbers of peripheral lymphocytes, and thus potentiating the effect of neoadjuvant chemotherapy.